Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 29, 2020Thrombosis and HaemostasisOpen Access

The Use of Recombinant Activated Factor VII in Patients with Glanzmann's Thrombasthenia

View Full Paper
Ask AI
Bookmark
Share

Authors

MPMan‐Chiu Poon

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Man‐Chiu Poon (2020) studied this question.

synapsesocial.com/papers/6a6a4ae3547974b2dbf3fc3ahttps://doi.org/10.1055/s-0040-1718373
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Glanzmann's thrombasthenia: pathogenesis, diagnosis, and current and emerging treatment options2015 · 125 citations
  2. 2Glanzmann's thrombasthenia: the spectrum of clinical disease1990 · 639 citations
  3. 3Alloimmunization in Congenital Deficiencies of Platelet Surface Glycoproteins: Focus on Glanzmann's Thrombasthenia and Bernard–Soulier's Syndrome2018 · 30 citations
  4. 4New Insights Into the Treatment of Glanzmann Thrombasthenia2016 · 148 citations
  5. 5Glanzmann’s thrombasthenia: strategies for identification and management2017 · 7 citations